Breast cancerBCCAR T cell therapyMahidol UniversityNational Research Council of ThailandDual BATs
…Background Breast cancer (BC) is the most common cancer among women worldwide and remain…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 10,621–10,680 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Neonatal orbital cellulitis1Neonatal osteomyelitis1Neonatal respiratory system immaturity1Neoplasm or Neoplasms1Nephrogenic diabetes insipidus1Nephropathy34391Neurocutaneous melanocytosis1Neurodegeneration-Multiple Diseases1Neurodegenerative pathologies1Neurodevelopmental delay1Neurodevelopmental disabilities (NDs)1Neuroendocrine carcinomas1Neuroendocrine lung tumours1Neurofascin 155 autoimmune nodopathy1Neurofibromatosis type 1-associated diffuse lung disease1Neurogenic bowel dysfunction (NBD)1Neurological diagnoses1Neuromuscular diseases (NMD)1Neuromyelitis optica spectrum disorder (NMOSD)1Neuromyelitis optica spectrum disorders (NMOSD)1Neuronal Ceroid Lipofuscinosis Type 21Neuronal intranuclear inclusion disease1Neuropathic incisional pain1Neuropathies1Neuropathy41461Neuropathy49201Neurotoxic myelitis1Nevus lipomatosus cutaneous superficialis1New York Heart Association class III or IV heart failure1Niemann-Pick C1Niemann-Pick type C1Nikolsky breast cancer1Nipah virus1Nocardia cyriacigeorgica1Nocardia keratitis1Node-first Kawasaki disease1Noise-induced hearing loss (NIHL)1Non alcoholic fatty liver disease (NAFLD)1Non- Hodgkin's Lymphoma1Non-24-hour sleep–wake rhythm disorder1Non-Hodgkin lymphoma101Non-ST-segment-elevation myocardial infarction1Non-acute subdural hematoma1Non-acute subdural hematomas1Non-ampullary duodenal adenomas1Non-aneurysmal subarachnoid haemorrhage1Non-battle injury1Non-compressible torso hemorrhage (NCTH)1Non-dilated left ventricular cardiomyopathy (NDLVC)1Non-dystrophic myotonia1Non-fatal TBI1Non-functioning pancreatic neuroendocrine tumours1Non-gestational choriocarcinomas1Non-insertional Achilles tendinopathy1Non-ischemic cerebral enhancing (NICE) lesions1Non-pancreatic periampullary carcinomas1Non-pedunculated colonic neoplasia (NPCN)1Non-segmental vitiligo1Non-specific low back pain (NSLBP)1Non-specific neck pain1
Articles mentioning diseases
23,712 articles · page 432 of 1976colorectal cancerpancreatic cancerPDACCRChuman cancerAZD0240TCR-T cell therapy
…uency, occurring in 28% and 12% of pancreatic cancer (PDAC) and colorectal cancer (CRC), respectively. KRAS G12D-containing peptides are presente…
93.5%
NSCLCmetastatic melanomaStage IV non-small cell lung cancerStage IV melanomaSARS-COV-2 mRNA vaccinesMD Anderson Cancer Center
…ociated with a near doubling of OS among patients with Stage IV NSCLC (555 days vs 1120 days, adj HR 0.5, 95% CI 0.4-0.7) and Stage I…
94.8%
melanomaUniversity of California IrvinenivolumabChao Family Comprehensive Cancer CenteripilimumabPD-1 immunotherapyαPD-1
… approval in 2014 but still fails in the majority of metastatic melanoma patients, emphasizing the need to further understand its impact…
stage IIB/C melanomastage IIB/IIC melanomastage IIB/C diseasestage IIB or IIC melanomaPembrolizumabFDAadjuvant immunotherapy
…, 32% of patients in the US received adjuvant immunotherapy for stage IIB/C melanoma and 21% within our healthcare system. The limited dissemination…
colorectal cancerCRCNivolumabNivoWCG Institutional Review Board
…(Nivo) is an anti-PD-1 immune checkpoint inhibitor approved for colorectal cancer (CRC), yet responses are highly variable between patients, and …
CRCMSS CRCWest China Hospital of Sichuan UniversityAkkInstitutional Review BoardimmunotherapyClinicalTrials.gov
…MSS CRC.Methods Preclinical studies used CT26 mouse models (MSS CRC) with oral Akk administration to assess tumor growth effects. T…
MSS mCRCMSS CRCMSS rectal canceratezolizumabvilastobartXTX101
…lizumab (1200mg Q3W) in heavily pretreated patients (n=44) with MSS mCRC, including 27 with non liver metastases (NLM). In an explorator…
myeloid leukemiaPROCPlatinum resistant ovarian cancerplatinum-resistant ovarian cancerovarian cancerECOG Performance StatusDana-Farber Cancer InstitutePHASE ONE FoundationIL-12IL-15+6 more
…ry-like natural killer cells exhibit enhanced responses against myeloid leukemia. Sci Transl Med. Sep 21 2016;8(357):357ra123. doi:10.1126/scitr…
oral head and neck squamous cell carcinomamelanomathyroid cancersolid tumorsAGX-148Providence Institutional Review BoardClinicalTrials.govlymphodepleting chemotherapy
…bserved in solid tumors including melanoma, thyroid cancer, and oral head and neck squamous cell carcinoma with responses lasting over 600 days in some patients. TCR sequ…
melanomanivolumabRP1Vusolimogene oderparepvecanti-PD-1 therapy
… review, and overall survival (OS) in patients with BRAF-mutant melanoma, stratified by prior BRAFi treatment (data cutoff: March 8, 202…
NeuroblastomaTemozolomideIrinotecandinutuximabaCD40University of Wisconsin
…Background Neuroblastoma is the most common pediatric solid cancer, outside of brain can…